Abstract
Astrocytes are the most abundant cells in the brain and play an important role in the homeostasis and maintenance of the brain. Furthermore, astrocytes play a key role in brain protection and in functional recovery from injuries. Impairment in astrocytes activity may promote neurodegeneration and, eventually, retraction of neuronal synapses, which leads to cognitive deficits found in neurodegenrative diseases, such as Alzheimers disease. Alzheimers disease (AD) is the most common type of dementia affecting more than 18 million people worldwide. The main cause of AD is generally attributed to the increased production and accumulation of amyloid-β (Aβ), in association with neurofibrillary tangle (NFT) formation. In AD patients brain, reactive astrocytes are integral components of neuritic plaques. Astrocytic activation seems to be particularly prominent around Aβ deposits both in the brain parenchyma and in the cerebrovasculature. Furthermore, recent evidence from AD patients suggests that pathological changes in the morphology of astrocyte occur prior to the appearance of Aβ plaques. The focus of this review is on astrocytic cells and their role in the progression of AD.
Keywords: Astrocyte, Alzheimer's disease, imflammation, neuroprotection, homeostasis, brain protection, amyloid-β, astrogliosis, astrocyte atrophy, neuroinflammation
Current Signal Transduction Therapy
Title: Targeting the Role of Astrocytes in the Progression of Alzheimers Disease
Volume: 7 Issue: 1
Author(s): Tal Iram and Dan Frenkel
Affiliation:
Keywords: Astrocyte, Alzheimer's disease, imflammation, neuroprotection, homeostasis, brain protection, amyloid-β, astrogliosis, astrocyte atrophy, neuroinflammation
Abstract: Astrocytes are the most abundant cells in the brain and play an important role in the homeostasis and maintenance of the brain. Furthermore, astrocytes play a key role in brain protection and in functional recovery from injuries. Impairment in astrocytes activity may promote neurodegeneration and, eventually, retraction of neuronal synapses, which leads to cognitive deficits found in neurodegenrative diseases, such as Alzheimers disease. Alzheimers disease (AD) is the most common type of dementia affecting more than 18 million people worldwide. The main cause of AD is generally attributed to the increased production and accumulation of amyloid-β (Aβ), in association with neurofibrillary tangle (NFT) formation. In AD patients brain, reactive astrocytes are integral components of neuritic plaques. Astrocytic activation seems to be particularly prominent around Aβ deposits both in the brain parenchyma and in the cerebrovasculature. Furthermore, recent evidence from AD patients suggests that pathological changes in the morphology of astrocyte occur prior to the appearance of Aβ plaques. The focus of this review is on astrocytic cells and their role in the progression of AD.
Export Options
About this article
Cite this article as:
Iram Tal and Frenkel Dan, Targeting the Role of Astrocytes in the Progression of Alzheimers Disease, Current Signal Transduction Therapy 2012; 7 (1) . https://dx.doi.org/10.2174/157436212799278232
DOI https://dx.doi.org/10.2174/157436212799278232 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial[Advanced MRI, MR as well as Optical Spectroscopy]
Current Medical Imaging Treatment of Viral Encephalitis
Central Nervous System Agents in Medicinal Chemistry Editorial: Thematic Issue-Topic–Diabetic Cardiovascular Disease–An Unmet Medical Need: Emerging Targets and Therapies-Introduction to the Special Issue
Cardiovascular & Hematological Agents in Medicinal Chemistry The Science of Hypoglycemia in Patients with Diabetes
Current Diabetes Reviews Effect of Polyherbal Drug Majun Falasfa on the Transgenic Drosophila Model of Parkinson’s Disease
Current Traditional Medicine Pharmacological Management of Hypertension in the Elderly - Certitudes and Controversies
Current Pharmaceutical Design Proteomic Alterations by Mutations Involved in Parkinson's Disease and Related Disorders
Current Protein & Peptide Science Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Other Anti- Inflammatory Agents in the Treatment of Neurodegenerative Disease
Current Alzheimer Research New Molecular Avenues in Parkinson ’ s Disease Therapy
Current Topics in Medicinal Chemistry The Concept of Phenoptosis and its Usefulness for Controlling Aging
Current Aging Science Rivastigmine Transdermal Patch and Physical Exercises for Alzheimer's Disease: A Randomized Clinical Trial
Current Alzheimer Research Stem Cell Pharmacogenomics
Current Topics in Medicinal Chemistry Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimers Disease
Current Medicinal Chemistry Roles of p75NTR in Maintaining Brain Hemostasis and the Implications for p75NTR-targeted Therapies
Current Alzheimer Research Vitamin E - Occurrence, Biosynthesis by Plants and Functions in Human Nutrition
Mini-Reviews in Medicinal Chemistry Trait vs. State Markers for Schizophrenia: Identification and Characterization Through Visual Processes
Current Psychiatry Reviews Shear Stress-sensitive Carriers for Localized Drug Delivery
Current Pharmaceutical Design miR-15b Suppression of Bcl-2 Contributes to Cerebral Ischemic Injury and is Reversed by Sevoflurane Preconditioning
CNS & Neurological Disorders - Drug Targets Multivariate Statistical Tools for the Evaluation of Proteomic 2D-maps:Recent Achievements and Applications
Current Proteomics (Pro)renin Receptor as a New Drug Target
Current Pharmaceutical Design